Fairfax Virginia Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: Fairfax
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Fairfax Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center The Fairfax Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding document that outlines the terms and conditions under which Gentling, Inc. can utilize the intellectual property rights owned by The University of North Texas Health Science Center. This agreement is crucial in fostering a productive collaboration between Gentling, Inc. and The University of North Texas Health Science Center. It enables Gentling, Inc. to have access to the Center's research findings, patents, copyrights, trade secrets, and any other intellectual property that is relevant to their collaborative project. Some key terms and provisions covered in this Fairfax Virginia Collateral License Agreement include: 1. Grant of License: The University of North Texas Health Science Center grants Gentling, Inc. a non-exclusive, non-transferable license to use their intellectual property for the purposes defined in the agreement. 2. Scope of Use: The agreement specifies the specific field or area in which Gentling, Inc. is authorized to use the licensed intellectual property. It may be limited to specific products, technology, or research areas. 3. Consideration: The agreement outlines the financial aspects of the collaboration, including any upfront or ongoing royalties to be paid by Gentling, Inc. to The University of North Texas Health Science Center for the use of their intellectual property. 4. Term and Termination: The agreement establishes the duration of the license and the conditions under which either party may terminate it. It may also include provisions for renewal or extension of the license. 5. Confidentiality: Both parties agree to keep confidential information shared during the collaboration strictly confidential and may include provisions for non-disclosure agreements to protect sensitive data or trade secrets. 6. Indemnification: The agreement may contain clauses stating that each party will indemnify the other from any claims, damages, or liabilities arising out of the use of licensed intellectual property or any breach of the agreement. 7. Dispute Resolution: In case of disputes, the agreement may outline the preferred method of resolving conflicts, such as mediation or arbitration, and the jurisdiction or venue in which legal actions should be taken. It is important to note that this description covers the general elements typically found in a Fairfax Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center. It is possible that various types of specific agreements can be established within this overarching framework, depending on the nature of the intellectual property, research projects, or other specific considerations.

Fairfax Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center The Fairfax Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding document that outlines the terms and conditions under which Gentling, Inc. can utilize the intellectual property rights owned by The University of North Texas Health Science Center. This agreement is crucial in fostering a productive collaboration between Gentling, Inc. and The University of North Texas Health Science Center. It enables Gentling, Inc. to have access to the Center's research findings, patents, copyrights, trade secrets, and any other intellectual property that is relevant to their collaborative project. Some key terms and provisions covered in this Fairfax Virginia Collateral License Agreement include: 1. Grant of License: The University of North Texas Health Science Center grants Gentling, Inc. a non-exclusive, non-transferable license to use their intellectual property for the purposes defined in the agreement. 2. Scope of Use: The agreement specifies the specific field or area in which Gentling, Inc. is authorized to use the licensed intellectual property. It may be limited to specific products, technology, or research areas. 3. Consideration: The agreement outlines the financial aspects of the collaboration, including any upfront or ongoing royalties to be paid by Gentling, Inc. to The University of North Texas Health Science Center for the use of their intellectual property. 4. Term and Termination: The agreement establishes the duration of the license and the conditions under which either party may terminate it. It may also include provisions for renewal or extension of the license. 5. Confidentiality: Both parties agree to keep confidential information shared during the collaboration strictly confidential and may include provisions for non-disclosure agreements to protect sensitive data or trade secrets. 6. Indemnification: The agreement may contain clauses stating that each party will indemnify the other from any claims, damages, or liabilities arising out of the use of licensed intellectual property or any breach of the agreement. 7. Dispute Resolution: In case of disputes, the agreement may outline the preferred method of resolving conflicts, such as mediation or arbitration, and the jurisdiction or venue in which legal actions should be taken. It is important to note that this description covers the general elements typically found in a Fairfax Virginia Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center. It is possible that various types of specific agreements can be established within this overarching framework, depending on the nature of the intellectual property, research projects, or other specific considerations.